Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens - PubMed

Comparative Study

Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens

C M Ahrén et al. Infect Immun. 1982 Oct.

Abstract

We studied the ability of antisera against different Escherichia coli surface antigens, both alone and in combination with anti-enterotoxin, to decrease fluid secretion induced by intestinal challenge with enterotoxigenic E. coli in rabbits. Antiserum against lipopolysaccharide protected significantly against O group homologous bacteria. Monospecific antisera against pilus-associated colonization factor antigens CFA/I and CFA/II were also effective, giving highly significant protection against enterotoxigenic E. coli strains bearing the corresponding colonization factor antigens. Protection was also observed with Fab fragments of the CFA/I antibodies. Addition of the anti-lipopolysaccharide serum to a protective antiserum against purified heat-labile enterotoxin resulted in an antisecretory effect which slightly exceeded the sum of the effects obtained with each preparation alone. The combination of antiserum against CFA/I or CFA/II with anti-enterotoxin gave protection that equaled the product of the effects obtained with each antiserum alone; i.e. the antisera cooperated synergistically.

Similar articles

• Immune protection against enterotoxinogenic E. coli: search for synergy between antibodies to enterotoxin and somatic antigens.

  Svennerholm AM, Ahrén C. Svennerholm AM, et al. Acta Pathol Microbiol Immunol Scand C. 1982 Feb;90(1):1-6. doi: 10.1111/j.1699-0463.1982.tb01409.x. Acta Pathol Microbiol Immunol Scand C. 1982. PMID: 7044040

• Adhesion of enterotoxigenic Escherichia coli in humans and animals.

  Levine MM. Levine MM. Ciba Found Symp. 1981;80:142-60. doi: 10.1002/9780470720639.ch10. Ciba Found Symp. 1981. PMID: 6114818 Review.

• Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.

  Zhang W, Sack DA. Zhang W, et al. Clin Vaccine Immunol. 2015 Sep;22(9):983-91. doi: 10.1128/CVI.00224-15. Epub 2015 Jul 1. Clin Vaccine Immunol. 2015. PMID: 26135975 Free PMC article. Review.

Cited by

• A First in Human Clinical Trial Assessing the Safety and Immunogenicity of Two Intradermally Delivered Enterotoxigenic Escherichia coli CFA/I Fimbrial Tip Adhesin Antigens with and without Heat-Labile Enterotoxin with Mutation LT(R192G).

  Gutiérrez RL, Riddle MS, Porter CK, Maciel M Jr, Poole ST, Laird RM, Lane M, Turiansky GW, Jarell A, Savarino SJ. Gutiérrez RL, et al. Microorganisms. 2023 Nov 2;11(11):2689. doi: 10.3390/microorganisms11112689. Microorganisms. 2023. PMID: 38004700 Free PMC article.

• A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.

  Bernstein DI, Pasetti MF, Brady R, Buskirk AD, Wahid R, Dickey M, Cohen M, Baughman H, El-Khorazaty J, Maier N, Sztein MB, Baqar S, Bourgeois AL. Bernstein DI, et al. Vaccine. 2019 Jan 21;37(4):602-611. doi: 10.1016/j.vaccine.2018.12.011. Epub 2018 Dec 15. Vaccine. 2019. PMID: 30563789 Free PMC article. Clinical Trial.

• Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.

  Osek J, Svennerholm AM, Holmgren J. Osek J, et al. Infect Immun. 1992 Nov;60(11):4961-4. doi: 10.1128/iai.60.11.4961-4964.1992. Infect Immun. 1992. PMID: 1356934 Free PMC article.

• Roles of different coli surface antigens of colonization factor antigen II in colonization by and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits.

  Svennerholm AM, Wennerås C, Holmgren J, McConnell MM, Rowe B. Svennerholm AM, et al. Infect Immun. 1990 Feb;58(2):341-6. doi: 10.1128/iai.58.2.341-346.1990. Infect Immun. 1990. PMID: 1967593 Free PMC article.

• A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.

  Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, Chakraborty S, Buchwaldt C, Darsley MJ. Harro C, et al. Clin Vaccine Immunol. 2011 Dec;18(12):2118-27. doi: 10.1128/CVI.05342-11. Epub 2011 Oct 12. Clin Vaccine Immunol. 2011. PMID: 21994354 Free PMC article. Clinical Trial.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information